125 related articles for article (PubMed ID: 16815351)
1. Serum insulin-like growth factor-I measurement in the follow-up of treated acromegaly: comparison of four immunoassays.
Massart C; Poirier JY
Clin Chim Acta; 2006 Nov; 373(1-2):176-9. PubMed ID: 16815351
[TBL] [Abstract][Full Text] [Related]
2. Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population.
Granada ML; Ulied A; Casanueva FF; Pico A; Lucas T; Torres E; Sanmartí A
Clin Endocrinol (Oxf); 2008 Jun; 68(6):942-50. PubMed ID: 17980002
[TBL] [Abstract][Full Text] [Related]
3. Applicability of recently established reference values for serum insulin-like growth factor 1: A comparison of two assays--an (automated) chemiluminescence immunoassay and an enzyme-linked immunosorbent assay.
Ivan D; Brabant G; Kann PH;
Clin Lab; 2005; 51(7-8):381-7. PubMed ID: 16122148
[TBL] [Abstract][Full Text] [Related]
4. Determination of serum insulin-like growth factor-I reference values for the immunometric Cisbio method on a large number of healthy subjects: clinical utility in the follow-up of patients with treated acromegaly.
Massart C; Poirier JY; Jard C; Pouchard M; Vigier MP
Clin Chim Acta; 2007 Jun; 381(2):176-8. PubMed ID: 17376419
[No Abstract] [Full Text] [Related]
5. Acromegaly and serum insulin-like growth factor I.
Thorner MO
Horm Res; 2004; 62 Suppl 1():34-6. PubMed ID: 15761230
[TBL] [Abstract][Full Text] [Related]
6. Measurement of insulin-like growth factor I (IGF-I) in normal adults, patients with liver cirrhosis and acromegaly: experience with a new competitive enzyme immunoassay.
Kratzsch J; Blum WF; Schenker E; Keller E; Jahreis G; Haustein B; Ventz M; Rotzsch W
Exp Clin Endocrinol; 1993; 101(3):144-9. PubMed ID: 8223982
[TBL] [Abstract][Full Text] [Related]
7. Determination of serum insulin-like growth factor-I reference values for the automated chemiluminescent Liaison® assay. Clinical utility in the follow-up of patients with treated acromegaly.
Massart C; Poirier JY
Clin Chim Acta; 2011 Jan; 412(3-4):398-9. PubMed ID: 21059350
[No Abstract] [Full Text] [Related]
8. Normal reference range of serum insulin-like growth factor (IGF)-I in healthy Thai adults.
Plengpanich W; Mangkala J; Buranasukajorn P; Boonruang K; Sunthornyothin S; Suwanwalaikorn S; Khovidhunkit W; Sridama V; Snabboon T
J Med Assoc Thai; 2008 Nov; 91(11):1681-4. PubMed ID: 19127789
[TBL] [Abstract][Full Text] [Related]
9. Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP).
Friedrich N; Alte D; Völzke H; Spilcke-Liss E; Lüdemann J; Lerch MM; Kohlmann T; Nauck M; Wallaschofski H
Growth Horm IGF Res; 2008 Jun; 18(3):228-37. PubMed ID: 17997337
[TBL] [Abstract][Full Text] [Related]
10. Clinical laboratory indices in the treatment of acromegaly.
Clemmons DR
Clin Chim Acta; 2011 Feb; 412(5-6):403-9. PubMed ID: 21075098
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum.
Berrigan D; Potischman N; Dodd KW; Nicar M; McQuillan G; Lavigne JA; Barrett JC; Ballard-Barbash R
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1017-22. PubMed ID: 17507631
[TBL] [Abstract][Full Text] [Related]
12. IGF-I and mortality in patients with acromegaly.
Strasburger CJ
J Endocrinol Invest; 2005; 28(11 Suppl International):78-80. PubMed ID: 16625852
[TBL] [Abstract][Full Text] [Related]
13. Two hour mean GH is not superior to basal GH for the follow-up of acromegalic patients treated with Octreotide LAR.
Taboada GF; Correa LL; de Oliveira Machado E; van Haute FR; Casini AF; Balarini GA; Neto LV; Calixto L; Calixto C; Gadelha MR
Growth Horm IGF Res; 2007 Feb; 17(1):77-81. PubMed ID: 17314058
[TBL] [Abstract][Full Text] [Related]
14. Pitfalls of insulin-like growth factor I assays.
Bidlingmaier M
Horm Res; 2009 Jan; 71 Suppl 1():30-3. PubMed ID: 19153502
[TBL] [Abstract][Full Text] [Related]
15. A novel mass spectrometry-based method for determining insulin-like growth factor 1: assessment in a cohort of subjects with newly diagnosed acromegaly.
Kay R; Halsall DJ; Annamalai AK; Kandasamy N; Taylor K; Fenwick S; Webb A; Wark G; Pleasance S; Gurnell M
Clin Endocrinol (Oxf); 2013 Mar; 78(3):424-30. PubMed ID: 23121616
[TBL] [Abstract][Full Text] [Related]
16. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
[TBL] [Abstract][Full Text] [Related]
17. Establishment of reference values for endocrine tests--part V: acromegaly.
Endert E; van Rooden M; Fliers E; Prummel MF; Wiersinga WM
Neth J Med; 2006; 64(7):230-5. PubMed ID: 16929084
[TBL] [Abstract][Full Text] [Related]
18. Detection of colorectal lesions by using autofluorescence colonoscopy in acromegalics and their relation to serum growth hormone and insulin-like growth factor-1 levels.
Matyja V; Kos-Kudla B; Foltyn W; Strzelczyk J; Latos W; Marek B; Kajdaniuk D; Karpe J; Ostrowska Z; Sieron-Stoltny K; Sieron A
Neuro Endocrinol Lett; 2006 Oct; 27(5):639-43. PubMed ID: 17159821
[TBL] [Abstract][Full Text] [Related]
19. Variation in GH and IGF-I assays limits the applicability of international consensus criteria to local practice.
Pokrajac A; Wark G; Ellis AR; Wear J; Wieringa GE; Trainer PJ
Clin Endocrinol (Oxf); 2007 Jul; 67(1):65-70. PubMed ID: 17437512
[TBL] [Abstract][Full Text] [Related]
20. Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II.
Frystyk J; Dinesen B; Orskov H
Growth Regul; 1995 Dec; 5(4):169-76. PubMed ID: 8745141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
